LY3473329 : Therapeutic Potential of Lipoprotein(a) Inhibitors
Pifithrin-α : Pifithrin-a protects against DNA damage-induced apoptosis downstream of mitochondria independent of p53
| AG-221 : Enasidenib in patients with mutant IDH2 myelodysplastic syndromes: a phase 1 subgroup analysis of the multicentre, AG221-C-001 trial
GANT61 : Gli signaling pathway modulates fibroblast activation and facilitates scar formation in pulmonary fibrosis
|
|
|
SB225002: Therapeutic inhibition of CXC chemokine receptor 2 by SB225002 attenuates LPS-induced acute lung injury in mice
